Reclast Lawsuit

Schmidt & Clark, LLP is No Longer Taking These Cases - If you feel that you may have a potential case, we urge you to contact another law firm adequately suited to handle your case.

Have you experienced negative side effects from the osteoporosis drug Reclast? Bisphosphonate medications like Reclast have been linked to unusual femur fractures, bone diseases and other serious side effects. If you took Reclast for an extended period of time and suffered from a femur fracture or other bone injury, please contact the Reclast lawyers at Schmidt & Clark, LLP for a free case evaluation.

What’s the problem?

Marketed and manufactured by Novartis A.G., Reclast (zoledronic acid) is a prescription bisphosphonate medication used in the treatment of osteoporosis, hypocalcemia, and certain types of cancer. What sets Reclast apart from the majority of other osteoporosis drugs is that it is designed to be administered just once a year via intravenous infusion, which some patients prefer to monthly or weekly administration. Unfortunately, Reclast has been linked to femur and hip fractures, as well as a serious bone disease called osteonecrosis of the jaw (ONJ). In October 2010, the U.S. Food & Drug Administration (FDA) announced that it was updating patient information to include warnings about the risk of atypical fractures of the thigh in individuals taking bisphosphonate medications like Reclast.

Side Effects of Reclast

There are a variety of side effects associated with Reclast. Our firm is pursing the following types of severe side effects:

  • Osteonecrosis of the Jaw (Dead Jaw)
  • Atypical femur fractures
  • Osteomyelitis
  • Pain
  • Swelling or infection of the gums
  • Loosening of the teeth
  • Poor healing of the gums
  • Numbness or a feeling of heaviness in the jaw
  • Drainage
  • Exposed bone
  • Hip Fractures
  • Renal failure

Reclast Hip Fracture Lawsuits

There have been numerous Reclast lawsuits brought against Novartis on behalf of patients who have developed hip fractures after taking the medication for an extended period of time (usually five years or longer). Especially troubling is the fact that these fractures are not just occurring in elderly individuals, but in younger patients as well. Younger women on hormone replacement therapy have been known to take Reclast for longer periods of time than post-menopausal women.

Awards & recognition